India's Pharmaceutical Exports

Country Profile

Guatemala

Guatemala is a growing market for Indian pharmaceuticals — $114M in FY 2025–26, with 5.1× growth over the past decade. Medicines accounts for 86% of shipments, with vaccines contributing $4.41M. The compound annual growth rate since FY2015 stands at 16.0%.

🇬🇹 $114M · 5.1× growth since FY2015 · 16.0% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$114M
Exports FY2025–26 DGCIS
5.1×
Growth FY2015→2026
16.0%
CAGR FY2015→2026
86%
Medicines Share
5
Product Categories Supplied
Guatemala is a growing market for Indian pharmaceuticals — $114M in FY 2025–26, with 5.1× growth over the past decade. Medicines accounts for 86% of shipments, with vaccines contributing $4.41M. The compound annual growth rate since FY2015 stands at 16.0%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $97.9M (85.7%) Medicine Ingredients $7.20M (6.3%) Vaccines $4.41M (3.9%) Surgical & Hospital Supplies $2.85M (2.5%) Traditional & Herbal $1.82M (1.6%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Guatemala in the RBI overseas direct investment dataset (2011–2026).